> It's generally very easy to marginally move the needle in drug discovery. It's very hard to move the needle enough to justify the cost.
Maybe this kind of AI-based exploration would lower the costs. The more something is automated, the cheaper it should be to test many concepts in parallel.
Maybe this kind of AI-based exploration would lower the costs. The more something is automated, the cheaper it should be to test many concepts in parallel.